These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32863772)

  • 1. MicroRNA-214-3p inhibits the stem-like properties of lung squamous cell cancer by targeting YAP1.
    Lu T; Yang Y; Li Z; Lu S
    Cancer Cell Int; 2020; 20():413. PubMed ID: 32863772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway.
    Kang R; Yao DF; Xu GZ; Zhou YH
    Neoplasma; 2020 Sep; 67(5):1094-1105. PubMed ID: 32538668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA ASAP1-IT1 enhances cancer cell stemness via regulating miR-509-3p/YAP1 axis in NSCLC.
    Liu Y; Yang Y; Zhang L; Lin J; Li B; Yang M; Li H; Chen K; Zhao W
    Cancer Cell Int; 2021 Oct; 21(1):572. PubMed ID: 34715859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop.
    Luo P; Wang Q; Ye Y; Zhang J; Lu D; Cheng L; Zhou H; Xie M; Wang B
    J Exp Clin Cancer Res; 2019 Feb; 38(1):74. PubMed ID: 30755230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-1285-3p is a potential prognostic marker in human osteosarcoma and functions as a tumor suppressor by targeting YAP1.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Cancer Biomark; 2019; 25(1):1-10. PubMed ID: 31006663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.
    Sun Z; Zhang Q; Yuan W; Li X; Chen C; Guo Y; Shao B; Dang Q; Zhou Q; Wang Q; Wang G; Liu J; Kan Q
    J Exp Clin Cancer Res; 2020 Nov; 39(1):250. PubMed ID: 33218358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
    Zheng Y; Duan L; Yang Y; Luo D; Yan B
    Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-375-3p inhibits the progression of laryngeal squamous cell carcinoma by targeting hepatocyte nuclear factor-1β.
    Chang K; Wei Z; Cao H
    Oncol Lett; 2020 Oct; 20(4):80. PubMed ID: 32863913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0000218 plays a carcinogenic role in laryngeal cancer through regulating microRNA-139-3p/Smad3 axis.
    Bai Y; Hou J; Wang X; Geng L; Jia X; Xiang L; Nan K
    Pathol Res Pract; 2020 Sep; 216(9):153103. PubMed ID: 32825967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitization effect of hsa-miR-138-2-3p on human laryngeal cancer stem cells.
    Zhu Y; Shi LY; Lei YM; Bao YH; Li ZY; Ding F; Zhu GT; Wang QQ; Huang CX
    PeerJ; 2017; 5():e3233. PubMed ID: 28533948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-27a-3p regulates epithelial to mesenchymal transition via targeting YAP1 in oral squamous cell carcinoma cells.
    Zeng G; Xun W; Wei K; Yang Y; Shen H
    Oncol Rep; 2016 Sep; 36(3):1475-82. PubMed ID: 27432214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory effect of microRNA-223-3p on breast cancer cell processes via the Hippo/Yap signaling pathway.
    Du T; Wang D; Wan X; Xu J; Xiao Q; Liu B
    Oncol Lett; 2021 Jul; 22(1):516. PubMed ID: 33986876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
    Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
    J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-146b-3p regulates proliferation of pancreatic cancer cells with stem cell-like properties by targeting MAP3K10.
    Zhou M; Gao Y; Wang M; Guo X; Li X; Zhu F; Xu S; Qin R
    J Cancer; 2021; 12(12):3726-3740. PubMed ID: 33995647
    [No Abstract]   [Full Text] [Related]  

  • 19. MicroRNA-330-3p represses the proliferation and invasion of laryngeal squamous cell carcinoma through downregulation of Tra2β-mediated Akt signaling.
    Cheng Y; Zhu H; Gao W
    Mol Cell Probes; 2020 Aug; 52():101574. PubMed ID: 32289378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
    Pan Y; Robertson G; Pedersen L; Lim E; Hernandez-Herrera A; Rowat AC; Patil SL; Chan CK; Wen Y; Zhang X; Basu-Roy U; Mansukhani A; Chu A; Sipahimalani P; Bowlby R; Brooks D; Thiessen N; Coarfa C; Ma Y; Moore RA; Schein JE; Mungall AJ; Liu J; Pecot CV; Sood AK; Jones SJ; Marra MA; Gunaratne PH
    Oncotarget; 2016 May; 7(18):25930-48. PubMed ID: 27036018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.